Merck

MERCK PFIZER

Marketed for Merck
avelumab
Packing/Price
1's
MIMS Class
Cancer Immunotherapy
ATC Classification
L01XC31 - avelumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.

Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in